Format

Send to

Choose Destination
Hum Mol Genet. 2019 Oct 10. pii: ddz237. doi: 10.1093/hmg/ddz237. [Epub ahead of print]

PAICS deficiency, a new defect of de novo purine synthesis resulting in multiple congenital anomalies and fatal outcome.

Author information

1
Université de Paris, INSERM UMR1163, Laboratory embryology and genetics of congenital malformation, Imagine Institute, F-75015 Paris, France.
2
Research Unit for Rare Diseases, Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital, 128 01 Prague, Czech Republic.
3
Pediatric Unit, Medical Department, The Faroese Hospital System, FO 100 Tórshavn, Faroe Islands.
4
Department of Biochemistry, University of Cambridge, CB2 1TN Cambridge, United Kingdom.
5
Department of Clinical Genetics, Rigshospitalet, 2100 Copenhagen, Denmark.
6
FarGen, The Genetic Biobank of the Faroe Islands, FO 100 Tórshavn, Faroe Islands.
7
CZ-OPENSCREEN, Institute of Molecular Genetics, Czech Academy of Sciences, 140 00 Prague, Czech Republic.
8
Section on Nephrology, Wake Forest School of Medicine, 271 03 Winston-Salem, NC, USA.

Abstract

We report for the first time an autosomal recessive inborn error of de novo purine synthesis (DNPS)-PAICS deficiency. We investigated two siblings from the Faroe Islands born with multiple malformations resulting in early neonatal death. Genetic analysis of affected individuals revealed a homozygous missense mutation in PAICS (c.158A>G; p.Lys53Arg) that affects the structure of the catalytic site of the bifunctional enzyme phosphoribosylaminoimidazole carboxylase (AIRC, EC 4.1.1.21)/phosphoribosylaminoimidazole succinocarboxamide synthetase (SAICARS, EC 6.3.2.6) (PAICS). The mutation reduced the catalytic activity of PAICS in heterozygous carrier's and patient's skin fibroblasts to approximately 50% and 10% of control levels, respectively. The catalytic activity of the corresponding recombinant enzyme protein carrying the mutation p.Lys53Arg expressed and purified from E.coli was reduced to approximately 25% of the wild type enzyme. Similar to other two known DNPS defects-adenylosuccinate lyase deficiency and AICA-ribosiduria, the PAICS mutation prevented purinosome formation in the patient's skin fibroblasts, and this phenotype was corrected by transfection with the wild-type but not the mutated PAICS. Although aminoimidazole ribotide (AIR) and aminoimidazole riboside (AIr), the enzyme substrates that are predicted to accumulate in PAICS deficiency, were not detected in patient's fibroblasts, the cytotoxic effect of AIr on various cell lines was demonstrated. PAICS deficiency is a newly described disease that enhances our understanding of the DNPS pathway and should be considered in the diagnosis of families with recurrent spontaneous abortion or early neonatal death.

PMID:
31600779
DOI:
10.1093/hmg/ddz237

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center